Humanized IgE/FcεR1 mouse model
Use the hIgE/hFcεR1 mouse model to successfully screen for innovative therapeutics for allergy, asthma and other IgE-mediated diseases.
![](https://cdn.prod.website-files.com/655b5a3d3d76e4eff6481da2/65b8bfab03e1c9348d5cf86f_cellule%201.png)
![](https://cdn.prod.website-files.com/655b5a3d3d76e4eff6481da2/65b8bfaacbee85e6e81e44c3_souris%201.png)
![](https://cdn.prod.website-files.com/655b5a3d3d76e4eff6481da2/65b8bfabf5f00b3aaec82ebf_rat%201.png)
A major limit for in vivo studies is the different cellular distribution of the IgE high-affinity receptor. In mice, the IgE high-affinity receptor is not expressed on monocytes/DCs, Langerhans cells, or eosinophils whereas it is in humans.
The model enables the production of a fully human IgE-FcεRI complex combined with a human-like expression of a FcεRI receptor.
hIgE/hFcεR1 model features
- Human-like cellular distribution (i.e., mast cells, basophils, monocytes/DCs, Langerhans cells, and eosinophils) of the FcεR1 receptor due to the presence of a minimal human promoter that drives its expression
- Physiological regulation and expression of the chimeric IgE/FcεR1 complex [humanized IgE/FcεR1 interactive domains (i.e., IgE Fc region and FcεR1 α-chain), and murine IgE Fab region and FcεR1 β- and γ-chains]
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/65e86c5984b3b128d7670eba_65845ec6fcf36f69022bc489_ige-fcer1_val_img00.webp)
Validation
Analysis of human FcεR1 and human IgE expression in double-humanized IgE/FcεR1 mouse cells.
Left panel: Expression of hFcεR1 α-chain from bone marrow-derived cultured mast cells (BMMCs) in presence of murine IL-3, stem cell factor (SCF) and IL-6 (8 weeks treatment).
Right panel: Expression of hFcεR1 on murine eosinophils in peripheral blood upon intravenous injection of eotaxin (2.4 nmol/kg).
Functional data on double-humanized IgE/FcεR1 mouse model
- Mast cells sensitization OVN with hIgE in the presence mAbs
- Stimulation with anti-hIgE
- β-hexosaminidase activity in cell supernatant determined as a percentage of total enzyme activity in cell lysates
Passive systemic anaphylaxis is inducible in hIgE/hFcER1 mouse model and inhibited by a specific anti-hIgE treatment
The model has been successfully used by Ambiotis, a Contract Research Organization (CRO) providing inflammation assays and lipid analytical services.
Discover related products to
hIgE/hFcεR1
![](https://cdn.prod.website-files.com/655b5a3d3d76e4eff6481da2/65b8bfaacbee85e6e81e44c3_souris%201.png)
hGITR/Foxp3
The hGITR/Foxp3 mouse enables the in vivo efficacy assessment and profiling of immuno-oncology agents targeting the human immune checkpoint GITR. The red fluorescent protein regulated under the Foxp3 promoter allows you to efficiently monitor and sort Foxp3-expressing cells from different lymphocyte lineages and lymphoid organs.
Humanized IgE/FcεR1 mouse model
Get in touch about
Let us know how we can help
Ultimate predictive models
Physiological relevance
Comprehensive and reliable validation data
Over 600 scientific articles based on our modelsScientific excellence
In-depth expertise in preclinical science, physiology, and model development
Unique R&D platform located in FranceCustomer-centric
Tailor-made approach to your needs
Strong emphasis on customer satisfactionCollaborative partner
Long-standing partnerships with 17 of the top 20 pharma companies
Co-development of innovative models for next-generation drugs
Guaranteed FTO/freedom to operate